Kemp J P
University of California, School of Medicine, San Diego.
Arch Intern Med. 1993 Apr 12;153(7):805-12.
As asthma prevalence continues to increase, so does its impact on public health and on health care systems. Despite the prescription of more antiasthma medications than ever before, morbidity and mortality associated with asthma continue to increase. The focus of asthma therapy is changing, with a greater emphasis on control of the inflammatory rather than the bronchoconstrictive component. Several sets of guidelines recently developed by groups of asthma specialists clearly reflect this new focus. While such recommendations are intended to help physicians more accurately diagnose asthma by severity and better manage its symptoms, uniformity in both areas is lacking. Disparities are seen not only among physicians overall but also among primary care physicians compared with subspecialists. New survey data help to illustrate how reality--the clinical approaches of these physician subgroups--differs from current recommendations. Physicians who treat patients with asthma may find that their approaches are in agreement with those of their peers. Nonetheless, they may also find that they deviate from guidelines that could improve clinical outcome for a substantial number of patients with asthma.
随着哮喘患病率持续上升,其对公众健康和医疗保健系统的影响也在增加。尽管目前开具的抗哮喘药物比以往任何时候都多,但与哮喘相关的发病率和死亡率仍在上升。哮喘治疗的重点正在发生变化,更加注重控制炎症成分而非支气管收缩成分。哮喘专家小组最近制定的几套指南清楚地反映了这一新重点。虽然这些建议旨在帮助医生更准确地根据严重程度诊断哮喘并更好地管理其症状,但在这两个方面都缺乏一致性。差异不仅存在于全体医生之间,与专科医生相比,初级保健医生之间也存在差异。新的调查数据有助于说明这些医生亚组的临床方法——即实际情况——与当前建议有何不同。治疗哮喘患者的医生可能会发现他们的方法与同行一致。然而,他们也可能发现自己偏离了那些可以改善大量哮喘患者临床结局的指南。